Navigation Links
AdvaMed 2010 Keynote Speakers Announced
Date:9/28/2010

WASHINGTON, Sept. 28 /PRNewswire-USNewswire/ -- AdvaMed 2010 is proud to announce its conference keynote speakers include: Centers for Medicare and Medicaid Services Administrator Dr. Donald Berwick; CBS Evening News Anchor Katie Couric; U.S. Food and Drug Administration Commissioner Dr. Margaret Hamburg; and U.S. Secretary of Commerce Gary Locke. Each will address hundreds of national and international medical device and technology leaders in Washington, D.C. October 18-20 during AdvaMed 2010: The MedTech Conference.

"We are pleased that so many of today's policy leaders and news makers will address AdvaMed 2010," said Stephen Ubl, president and CEO of the Advanced Medical Technology Association (AdvaMed) as he announced elements of the AdvaMed 2010 (www.AdvaMed2010.com) program. "Our keynote speakers directly impact the policies that regulate, reimburse, and allow us to export our technologies, as well as those that advocate the benefits of these life changing innovative medical technologies and devices. We look forward to hearing their remarks, showing them our innovations, and participating in a constructive and engaging dialogue."

AdvaMed 2010: The MedTech Conference will open on Monday, October 18 with a series of Executive Workshops.  Workshop topics range from bringing medical devices to the U.S. market to harmonization and an entrepreneurship bootcamp. AdvaMed 2010 encompasses 39 educational panels, 62 innovative company presentations, more than 70 exhibiting companies, and a series of sector and industry networking events.

The first AdvaMed 2010 keynote address will take place on Tuesday, October 19, 2010 at the Walter E. Washington Convention Center. The 7:30 am keynote will feature Dr. Donald Berwick, Administrator of the Centers for Medicare & Medicaid Services (CMS).  Dr. Berwick has an extensive background in h
'/>"/>

SOURCE AdvaMed 2010; AdvaMed
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AdvaMed Selects Prolifiq as Member of Business Solutions Program
2. AdvaMed Releases New Survey Results on DTC Campaigns
3. Vibrant Exhibit Hall Features Innovative Medical Technology at AdvaMed 2009
4. Medical Technology Executives Descend on D.C. as AdvaMed 2009: The MedTech Conference Kicks Off and Health Care Debate Continues
5. Adnavance Technologies to Present Initial Data Supporting Direct Detection Molecular Diagnostic Tests at AdvaMed 2009 and BIOCOM Investor Conference
6. Food and Drug Administration Expert to Deliver Keynote Address
7. Speakers to Focus on Translating Regenerative Medicine Science
8. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
9. Encorium Group, Inc. Provides Update on Its Previously Announced Rights Offering
10. PharmAthene Completes Previously Announced Registered Direct Offering
11. Formation of Contract Parenteral Drug Development Services Company Announced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: Global ... Systems -- Focus on End Users ... OBJECTIVES A drug delivery system ...
(Date:1/15/2014)... CAMBRIDGE, Mass. , Jan. 15, 2014  Zafgen, ... the unmet needs of severely obese patients, today ... of beloranib, a selective inhibitor of methionine aminopeptidase ... a severe form of genetic obesity.  These results ...
(Date:1/14/2014)... HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... for the fourth quarter of 2013 will be approximately ... $208 million. "Our full-year revenue growth of ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
(Date:4/23/2014)... Oncotarget , explored tumour heterogeneity where ... DNA signatures within the same cancer. Such differences ... treatment strategies. , Firstly they confirmed the mutual ... KRAS or BRAF mutation. Secondly, they found that ... have that specific mutation present uniformly throughout the ...
(Date:4/23/2014)... of endogenous neural precursor cells cannot alone compensate ... the perspective of neural plasticity, Dr. Yun Xiang ... observed the effects of functional electrical stimulation treatment ... of basic fibroblast growth factor and epidermal growth ... side. The researchers found that functional electrical stimulation ...
(Date:4/22/2014)... the United States with 1 million participants annually. A ... Injury Research and Policy at Nationwide Children,s Hospital is ... distribution patterns of basketball-related injuries treated in emergency departments ... and teens. , The study, published online in the ... to adolescents 13-19 years of age who were treated ...
(Date:4/22/2014)... recently FDA-approved device has been shown to reduce seizures ... 50 percent. When coupled with an innovative electrode placement ... facilitated the complete elimination of seizures in nearly half ... clinical trials. , That,s good news for a large ... living with epilepsy whose seizures can,t be controlled with ...
(Date:4/22/2014)... that can provide primary care for low-income patients ... and insurance companies while improving patient health, researchers ... suggests that health clinics that avoid costs associated ... by lowering hospital admission rates and emergency room ... Penn State Altoona. , The researchers estimated ...
Breaking Medicine News(10 mins):Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2Health News:New study finds 2.5 million basketball injuries to high school athletes in 6 seasons 2Health News:New study finds 2.5 million basketball injuries to high school athletes in 6 seasons 3Health News:Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy 2Health News:Clinics not bogged down by red tape can ease health cost burdens 2
... recommended treatments, study found , FRIDAY, May 28 (HealthDay ... designed to review current research and guidelines, doctors made ... patients with high blood pressure, a new study reports. ... reflected in the practices of community physicians remains a ...
... Chase Cancer Center investigators find that pancreatic cancer patients who ... patients without circulating tumor cells. Additionally, the team has uncovered ... and some may predict worse outcomes than others. Benjamin ... will present the study at the 46th Annual Meeting of ...
... the final details on how two stroke-prevention procedures are safe ... stroke, though their effectiveness does vary by age, say researchers ... Public Health in collaboration with other North American stroke investigators. ... Journal of Medicine (NEJM) May 26, the researchers say ...
... ... range of crystalens to benfit the patients. , ... (Vocus) -- Dr. Khanna and crystal lens have had a symbiotic relationship ... has especially been helpful in people who have undergone radial RK or macular degeneration. ...
... to be self-centered, competitive, U.S. research shows , FRIDAY, May ... reveals that American college students are not quite as empathetic ... drop in empathy after the year 2000," co-author Sara Konrath, ... Research, said in a news release. "College kids today are ...
... brain, still befuddles patients and researchers, , FRIDAY, May 28 ... be a lifeline to the future. And more aggressive, high-dose ... there,s a downside, too: Chemotherapy is linked to a mental ... dismissed as "all in your head," but that,s no longer ...
Cached Medicine News:Health News:Putting New Medical Guidelines Into Practice Often Difficult 2Health News:Circulating tumor cells correlate with poorer survival in pancreatic cancer patients 2Health News:Age is a factor in choosing between two comparable stroke-prevention procedures 2Health News:Khannna Institute to offer Crystalens in Quarter Diopter Steps 2Health News:Today's College Students More Likely to Lack Empathy 2Health News:Making Your Way Through the Fog of Chemotherapy 2Health News:Making Your Way Through the Fog of Chemotherapy 3
Pneumatic oscillating saw, 35k cpm, available with various hose connector styles....
... Motor Module, with hand throttle. Accepts all ... , 10ft. air hose 9000-000, or existing ... air hose 9013-000, or existing hose with ... 9014-000, or existing hose with 3M connector ...
Pneumatic extended oscillating saw, 35k cpm, available with various hose connector styles....
Pneumatic pencil-grip wire driver, 3000 rpm, available with various hose connector styles....
Medicine Products: